Denna sida på svenska
Loading profile information...

Publications

Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
Kavaliunas A, Danylaite Karrenbauer V, Gyllensten H, Manouchehrinia A, Glaser A, Olsson T, et al
Multiple sclerosis (Houndmills, Basingstoke, England) 2019;25(1):104-112

Cognitive function predicts work disability among multiple sclerosis patients
Kavaliunas A, Tinghög P, Friberg E, Olsson T, Alexanderson K, Hillert J, et al
Multiple sclerosis journal - experimental, translational and clinical 2019;5(1):2055217318822134-

Different Interferon Beta Preparations Induce the Same Qualitative Immune Response in Human Skin
Hermanrud C, Van Capel Tmm, Auer M, Karrenbauer V, Deisenhammer F, De Jong Ec, et al
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2019;39(5):302-313

Cognitive function predicts work disability among multiple sclerosis patients
Kavaliunas A, Karrenbauer Vd, Tinghog P, Friberg E, Olsson T, Alexanderson K, et al
MULTIPLE SCLEROSIS JOURNAL 2017;:479-480

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
Vågberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y, et al
Acta neurologica Scandinavica 2017;135(1):17-24

Income in Multiple Sclerosis Patients with Different Disease Phenotypes
Kavaliunas A, Manouchehrinia A, Karrenbauer Vd, Gyllensten H, Glaser A, Alexanderson K, et al
PLOS ONE 2017;12(1):e0169460-

Oligoclonal immunoglobulin gamma bands in the cerebrospinal fluid confers higher risk to reach EDSS milestones and to convert to secondary progression
Karrenbauer Vd, Manouchehrinia A, Hillert J
MULTIPLE SCLEROSIS JOURNAL 2017;:994-994

Similar familial risk in multiple sclerosis subgroups
Song J, Karrenbauer V, Manouchehrinia A, Almqvist C, Hillert J, Westerlind H
Multiple sclerosis (Houndmills, Basingstoke, England) 2017;23(13):1782-1785

CSF Markers of Inflammation and Neurodegeneration in Two Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS) Families with Diverging Genotype and Phenotype
Karrenbauer V, Zetterberg H, Sundal C, Andersen O
NEUROLOGY 2016;

Factors that changes carriership status of oligoclonal immunoglobulin gamma bands in cerebrospinal fluid in MS during follow up time, -registry based study
Karrenbauer Vd, Hillert J, Manouchehrinia A
MULTIPLE SCLEROSIS JOURNAL 2016;:586-587

Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls
Granberg T, Hashim F, Andersen O, Sundal C, Karrenbauer Vd
European journal of neurology 2016;23(4):817-22

Income among multiple sclerosis patients with different disease phenotypes
Kavaliunas A, Manouchehrinia A, Karrenbauer Vd, Gyllensten H, Glaser A, Alexanderson K, et al
MULTIPLE SCLEROSIS JOURNAL 2016;:460-461

Income and cognitive impairment among multiple sclerosis patients.
Kavaliunas A, Karrenbauer Vd, Gyllensten H, Manouchehrinia A, Glaser A, Alexanderson K, et al
MULTIPLE SCLEROSIS JOURNAL 2016;:12-13

Oligoclonal Immunoglobulin Gamma Bands in the Cerebrospinal Fluid and Risk of Conversion to Secondary Progress in Multiple Sclerosis
Karrenbauer V, Hillert J, Manouchehrinia A
NEUROLOGY 2016;

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, et al
European journal of neurology 2015;22(2):328-333

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis
Novakova L, Axelsson M, Malmeström C, Zetterberg H, Björkhem I, Karrenbauer Vd, et al
Journal of the neurological sciences 2015;358(1-2):201-6

Interferon beta treatment of multiple sclerosis increases serum interleukin-7
Lundström W, Hermanrud C, Sjöstrand M, Brauner S, Wahren-herlenius M, Olsson T, et al
Multiple sclerosis (Houndmills, Basingstoke, England) 2014;20(13):1727-36

Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund Lo, et al
Journal of neuroimmunology 2014;274(1-2):149-54

Number of OCBs in CSF at diagnosis timepoint,- predictor of long term radiological outcome in MS?
Karrenbauer Vd, Evertsson B, Stawiarz L, Imrell K, Voevodskayac O, Wahlund Lo, et al
JOURNAL OF NEUROIMMUNOLOGY 2014;275(1-2):16-17

Cerebrosterol levels in serum: does it reflect axonal damage in CNS?
Novakova L, Malmestrom C, Axelsson M, Masterman T, Bjorkhem I, Hillert J, et al
MULTIPLE SCLEROSIS JOURNAL 2013;19(11):299-299

Elevated Plasma IL-7 Levels in Multiple Sclerosis Patients Treated with Interferon Beta are Caused by Decreased Cell Consumption
Hermanrud C, Lundstrom W, Sjostrand M, Brauner S, Wahren-herlenius M, Olsson T, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2013;77(4):316-316

Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients
Karrenbauer Vd, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K
Journal of neuroimmunology 2013;254(1-2):170-3

Cross-sectional study on relationship between Symbol Digit Modalities Test, plasma cerebrosterol concentration and MRI-based brain volumes of MS patients
Bergendal G, Stawiarz L, Almkvist O, Fredrikson S, Glaser A, Hillert J, et al
EUROPEAN JOURNAL OF NEUROLOGY 2012;:711-711

Impact of OCB status and HLA-DRB1 risk alleles on lesion load in MS patients at age 40
Karrenbauer V, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K
EUROPEAN JOURNAL OF NEUROLOGY 2012;:352-352

Interferon-beta therapy-induced elevation of serum IL-7 levels is blocked by anti-drug antibodies
Hermanrud C, Lundstrom W, Karrenbauer V, Hillert J, Fogdell-hahn A
JOURNAL OF NEUROIMMUNOLOGY 2012;253(1-2):69-70

Interferon-Beta Therapy-Induced Elevation of Serum IL-7 Levels is Blocked by Anti-Drug Antibodies
Hermanrud C, Lundstrom W, Karrenbauer V, Hillert J, Fogdell-hahn A
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2012;76(2):200-201

Monogenetic Multiple Sclerosis or Spastic Paraplegia with Inflammation in a Consanguineous Family?
Imrell K, Karrenbauer V, Bomfim Il, Roshanisefat H, Lamb B, Hillert J, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2012;76(2):207-207

MS disease related variables and its impact on gray matter volume and cortical thickness
Karrenbauer Vd
JOURNAL OF NEUROIMMUNOLOGY 2012;253(1-2):19-19

Plasma cerebrosterol measures predict cognitive processing speed deterioration 7 years later in MS patients
Stawiarz L, Bergendal G, Almkvist O, Fredrikson S, Link J, Leoni V, et al
MULTIPLE SCLEROSIS JOURNAL 2012;:496-497

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Maestro-01 Investigators, Freedman Ms, Bar-or A, Oger J, Traboulsee A, Patry D, et al
Neurology 2011;77(16):1551-60

Comparison of MRI lesion location in multiple sclerosis patients with and without oligoclonal bands in the cerebrospinal fluid
Karrenbauer Vd, Prejs R, Imrell K, Glaser A, Masterman T, Hillert J
JOURNAL OF NEUROLOGY 2011;:154-155

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [C-11]vinpocetine and [C-11]PK11195 in patients
Vas A, Shchukin Y, Karrenbauer Vd, Cselenyi Z, Kostulas K, Hillert J, et al
JOURNAL OF THE NEUROLOGICAL SCIENCES 2008;264(1-2):9-17

Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis
Liu Gz, Gomes Ac, Putheti P, Karrenbauer V, Kostulas K, Press R, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2006;64(4):412-9

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis
Karrenbauer Vd, Leoni V, Lim Et, Giovannoni G, Ingle Gt, Sastre-garriga J, et al
CLINICAL NEUROLOGY AND NEUROSURGERY 2006;108(5):456-60

Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis
Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer Vd, et al
JOURNAL OF NEUROIMMUNOLOGY 2005;167(1-2):210-4

Show all publications